Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Array Biopharma Inc (NASDAQ:ARRY)

11.36
BATS BZX Real-Time Price
As of 2:00pm ET
 +0.15 / +1.34%
Today’s Change
6.73
Today|||52-Week Range
13.40
+29.24%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues44.5M33.3M33.8M29.7M
 
 
 
 
 
Cost of Goods Sold8.5M6.9M9.5M11.2M
 
 
 
 
 
Depreciation And Amortization496.0K528.0K569.0K577.0K
 
 
 
 
 
 
Operating ExpensesGross Income35.5M25.8M23.7M18.0M
 
 
 
 
 
General Expenses55.3M57.8M50.0M53.5M
 
 
 
 
 
Research And Development46.5M46.1M39.1M41.4M
 
 
 
 
 
Total Operating Expenses64.3M65.2M60.1M65.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-19.8M-31.9M-26.3M-35.5M
 
 
 
 
 
Extraordinary Credit0.000.000.00200.0K
 
 
Extraordinary Charge-600.0K-1.3M-500.0K0.00
 
 
 
 
Interest Expense On Debt3.1M3.1M3.2M3.2M
 
 
 
 
 
Other Expenses0.00785.0K112.0K0.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-23.3M-35.3M-29.6M-38.0M
 
 
 
 
 
Net Income-23.3M-35.3M-29.6M-38.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS168.1M169.0M170.8M174.8M
 
 
 
 
 
Shares To Calculate EPS Diluted168.1M169.0M170.8M174.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.14-$0.21-$0.17-$0.22
 
 
 
 
 
EPS Diluted-$0.14-$0.21-$0.17-$0.22